Task: Answer the multiple choice question.
Query: Which drug exhibits a -13.180\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a Cn1ncc2cc(NC(N)=S)ccc21
b CCOC(=O)N1CCN(c2nnc(-c3ccc(C)cc3)c3ccccc23)CC1
c CCCCCCCC(=O)N/N=C/c1ccc([N+](=O)[O-])o1
d CC(C)C(C(=O)Nc1ccc2c(c1)OCCOCCOCCOCCO2)N1C(=O)c2ccccc2C1=O
Answer: d. CC(C)C(C(=O)Nc1ccc2c(c1)OCCOCCOCCOCCO2)N1C(=O)c2ccccc2C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)C(C(=O)Nc1ccc2c(c1)OCCOCCOCCOCCO2)N1C(=O)c2ccccc2C1=O
CC(C)C(C(=O)Nc1ccc2c(c1)OCCOCCOCCOCCO2)N1C(=O)c2ccccc2C1=O
2-(1,3-dioxoisoindol-2-yl)-3-methyl-N-(2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(19),15,17-trien-17-yl)butanamide